1.
Kyei-Baffour K, Davis DC, Boskovic Z, Kato N, Dai M. Natural product-inspired aryl isonitriles as a new class of antimalarial compounds against drug-resistant parasites. Bioorg Med Chem. 2020;28(19):115678. doi:10.1016/j.bmc.2020.115678.
1.
Hung DT, Jamison TF, Schreiber SL. Understanding and controlling the cell cycle with natural products. Chem Biol. 1996;3(8):623-39.
1.
Altmann K-H, Buchner J, Kessler H, et al. The state of the art of chemical biology. Chembiochem. 2009;10(1):16-29. doi:10.1002/cbic.200800758.
1.
Comer E, Duvall JR, Lee M duPont. Utilizing diversity-oriented synthesis in antimicrobial drug discovery. Future Med Chem. 2014;6(17):1927-42. doi:10.4155/fmc.14.111.
1.
Marcaurelle LA, Comer E, Dandapani S, et al. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. J Am Chem Soc. 2010;132(47):16962-76. doi:10.1021/ja105119r.
1.
de la Fuente-Núñez C, Torres MD, Mojica FJ, Lu TK. Next-generation precision antimicrobials: towards personalized treatment of infectious diseases. Curr Opin Microbiol. 2017;37:95-102. doi:10.1016/j.mib.2017.05.014.
1.
Wills JW, Summers HD, Hondow N, et al. Characterizing Nanoparticles in Biological Matrices: Tipping Points in Agglomeration State and Cellular Delivery In Vitro. ACS Nano. 2017;11(12):11986-12000. doi:10.1021/acsnano.7b03708.
1.
Cao J, Perez-Pinera P, Lowenhaupt K, et al. Versatile and on-demand biologics co-production in yeast. Nat Commun. 2018;9(1):77. doi:10.1038/s41467-017-02587-w.
1.
Dančík V, Seiler KP, Young DW, Schreiber SL, Clemons PA. Distinct biological network properties between the targets of natural products and disease genes. J Am Chem Soc. 2010;132(27):9259-61. doi:10.1021/ja102798t.
1.
Duffner JL, Clemons PA, Koehler AN. A pipeline for ligand discovery using small-molecule microarrays. Curr Opin Chem Biol. 2007;11(1):74-82. doi:10.1016/j.cbpa.2006.11.031.